Failing Fontan Following Total Cavopulmonary Connection: Extracardiac Biomarkers Reveal 2 Distinct Phenotypes With Divergent Clinical Courses
Open Access
- 30 July 2026
- journal article
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (8)
Abstract
Objectives: Failing Fontan is an increasingly recognized complication after total cavopulmonary connection (TCPC), yet longitudinal biomarker data remain scarce. We aimed to characterize the incidence, biomarker trajectories, and prognostic determinants of failing Fontan. Methods: All patients who underwent primary TCPC (n = 650) or conversion to TCPC (n = 19) at our centre between 1994 and 2022 were reviewed. Lymphocyte count, N-terminal pro-brain natriuretic peptide (NT-proBNP) and its zlog value, and Fibrosis-4 index were assessed at 1 year before, 6 months before, at onset, and at last follow-up. Patients were classified into protein-losing enteropathy (PLE)/plastic bronchitis (PB) and heart failure phenotypes. Results: Failing Fontan developed in 78 primary TCPC patients (12.0%) and 12 conversion patients (63.2%). Conversion patients developed failing Fontan earlier (P < .001), but survival after onset was comparable. Lymphocyte counts declined before onset (2.49 to 0.89 × 10³/µL, P < .001) and the Fibrosis-4 index increased (0.060 to 0.330, P < .001). Phenotypes showed divergent profiles: zlog-NT-proBNP at onset was 0.71 in PLE/PB versus 5.34 in heart failure (P < .001). Lymphocytopenia (LP) predicted mortality early (hazard ratio 6.77, P = .013) but appeared protective at last follow-up (hazard ratio 0.18, P = .049), reflecting a phenotypic shift. On multivariable analysis, lower lymphocyte count independently predicted mortality (hazard ratio 2.44, P = .041), while stent implantation was independently associated with lower mortality (hazard ratio 0.32, P = .040). Conclusions: Lymphocyte counts and the Fibrosis-4 index change progressively before clinical onset and may serve as early warning biomarkers. The prognostic interpretation of LP depends on the underlying phenotype, underscoring the need for phenotype-aware monitoring.Keywords
Funding Information
- Förderverein des Deutschen Herzzentrums München
This publication has 18 references indexed in Scilit:
- Lymphopenia in the Adult Population With Fontan Physiology: A Potential New Marker for Disease AssessmentCJC Open, 2024
- Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNPJACC, 2021
- Non-invasive biomarkers of Fontan-associated liver diseaseJHEP Reports, 2021
- Lymphopenia in adults after the Fontan operation: prevalence and associationsCardiology in the Young, 2020
- Clinical Outcomes in Adolescents and Adults After the Fontan ProcedureJACC, 2018
- Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac DiseaseThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- Conversion to Total Cavopulmonary Connection Improves Functional Status Even in Older Patients with Failing Fontan CirculationThe Thoracic and Cardiovascular Surgeon, 2015
- Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST studyInternational Journal of Cardiology, 2013
- Nonfenestrated Extracardiac Total Cavopulmonary Connection in 132 Consecutive PatientsThe Annals of Thoracic Surgery, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006